Tandem Diabetes Care (TNDM)
(Real Time Quote from BATS)
$48.86 USD
+0.01 (0.02%)
Updated Jun 10, 2024 10:46 AM ET
3-Hold of 5 3
D Value D Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TNDM 48.86 +0.01(0.02%)
Will TNDM be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for TNDM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TNDM
Why Is OPKO Health (OPK) Up 12.8% Since Last Earnings Report?
Here's Why You Should Hold on to Tandem Diabetes (TNDM) Now
TNDM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tandem Diabetes (TNDM) Connects Mobi Pump With Dexcom G7 Sensor
Tandem Diabetes (TNDM) Hits 52-Week High: What's Driving It?
Tandem Diabetes (TNDM) Posts Narrower Q1 Loss, Raises '24 View
Other News for TNDM
AMD To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Monday
Analysts’ Top Healthcare Picks: Sagimet Biosciences, Inc. Class A (SGMT), Galecto (GLTO)
Tandem Diabetes price target raised by $11 at Oppenheimer, here's why
Stocks with the highest and lowest liquidity - Goldman Sachs
Tandem Diabetes’ (NASDAQ:TNDM) Stocks Surges, But Faces fierce Competition